Discover a study revealing how prebiotics improve acne vulgaris by balancing the skin microbiome and enhancing collagen for ...

Patient-reported outcome (PRO) measures were included in approximately one-half of acne vulgaris and rosacea randomized controlled trials, despite their utility in capturing the patient perspective.

The first FDA-approved acne drug with a first-in-class mechanism of action in nearly 40 years launched in the United States in November 2021 after being approved in August 2020. The first-in-class ...

Today, Sagimet Biosciences Inc. (NASDAQ:SGMT) and its partner in China, Ascletis Bioscience, reported positive results from a phase 3 study using Fatty Acid Synthase (FASN) inhibitor denifanstat for ...